Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 152.20
+2.70 (1.81%)
Nov 6, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 11.98 billion as of November 6, 2026. It is the 7,753rd most valuable company in the world and the 390th biggest in Hong Kong. Its market cap has increased by 33.51% in one year.
Market Cap
11.98B
Enterprise Value
10.45B
Revenue
685.64M
Global Rank
Country Rank
#390 Hong Kong
PE Ratio
66.02
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 11.98B, an increase of 46.07%. That is a compound annual growth rate of 43.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 11.98B | 11.91% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 22.32B |
| The United Laboratories International Holdings | 15.67B |
| Grand Pharmaceutical Group | 15.58B |
| CanSino Biologics | 13.50B |
| Consun Pharmaceutical Group | 13.24B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Shandong Xinhua Pharmaceutical Company | 8.51B |
| SSY Group | 7.60B |